Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148889A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
10/31/2001EP1148888A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
10/31/2001EP1148886A2 Use of a polyanionic polysaccharide solution for the prevention of abscess formation
10/31/2001EP1148884A1 Graduated progestin contraceptive
10/31/2001EP1148883A1 Method for treatment of headache
10/31/2001EP1148882A1 Pharmaceutical combination of progesterone and folic acid
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001EP1148879A2 Use of pyrazole carboxamides
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001EP1148874A1 Use of anticonvulsant derivatives for treating bulimia nervosa
10/31/2001EP1148873A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
10/31/2001EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/31/2001EP1148871A1 Core tablet for controlled release of gliclazide after oral administration
10/31/2001EP1148870A1 Anti-plaque emulsions and products containing same
10/31/2001EP1148793A1 Method of preparing microparticles of phytosterols or phytostanols
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP1043988A4 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
10/31/2001EP0991670B1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
10/31/2001EP0980248B1 Improvements in or relating to long-acting antimicrobials
10/31/2001EP0902780B1 Quaternary cytofectins
10/31/2001EP0901466B1 Biphenylsulfonamide matrix metalloproteinase inhibitors
10/31/2001EP0888292B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY ALPHAvBETA3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/31/2001EP0888286B1 Novel substituted cyclic amino acids as pharmaceutical agents
10/31/2001EP0877026B1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001EP0876144B1 Therapeutic anti-asthma agents containing ebselen
10/31/2001EP0869946B1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/31/2001EP0869806B1 A pharmaceutical composition comprising plant worms and muirapuama
10/31/2001EP0833652A4 Novel kappa receptor selective opioid peptides
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0819124B1 Azole compounds with antimycotic activity for human and veterinary use
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001EP0800524B1 6-[triazolyl[ 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones
10/31/2001EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001EP0775157B1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001EP0760649B1 Fluticasone propionate formulations
10/31/2001EP0759760B1 Wound healing agent
10/31/2001EP0754180B1 Anti-helicobacter ester and carbamate derivatives of azolones
10/31/2001EP0747381B1 Carbapenem derivative
10/31/2001EP0743943B1 Pyridyl imidazole derivatives and processes for the preparation thereof
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001EP0717620B1 Substituted 2-aminotetralins
10/31/2001EP0716598B1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
10/31/2001EP0627918B1 New use of omega-3-fatty acids
10/31/2001EP0624160B1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
10/31/2001DE10021256A1 Neue, photolabile Cumarinylmethylester von cyclischen Nucleotiden, Verfahren zu deren Herstellung und ihre Verwendung New photolabile coumarinylmethyl esters of cyclic nucleotides, processes for their preparation and their use
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10020852A1 Antitumor agents having antimitotic and tubulin polymerization inhibiting action, comprising new or known 2-acyl-indole derivatives or aza analogs
10/31/2001DE10020813A1 Verwendung von N2-substituierten Benz[f]indazol-4,9-chinonen als Antiparasitika Use of N2-substituted benz [f] indazole-4,9-quinones as antiparasitic
10/31/2001DE10020812A1 Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika Use of Naphthindazol-4,9-quinones as antiparasitic
10/31/2001DE10019235A1 Neue Flavonglykosid-Derivate für den Einsatz in Kosmetika, Pharmazeutika und Ernährung New flavone derivatives for use in cosmetics, pharmaceuticals and nutrition
10/31/2001CN1320166A Fermentation of clavulanic acid at a controlled level of ammonia
10/31/2001CN1320128A Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B
10/31/2001CN1320127A New cytotoxic tris (oxazole)-containing macrolides
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001CN1320125A Trizolopyridines for the treamtent of thrombosis disorders
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320120A Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320041A Treatment of hepatitis B infection with thymosin alpha 1 and lamivudine
10/31/2001CN1320038A 2-methyl-thieno-benzodiazepine formulation
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1320036A Methods and compositions for treating gastro-esophageal reflux disease
10/31/2001CN1320035A Antibiotic compositions for treatment of the eye, ear and nose
10/31/2001CN1320034A Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacturing of medicament for intraspinal, intrathecal or epidural edministration
10/31/2001CN1320028A Method of treating hair loss using sulfonamides
10/31/2001CN1319674A Sieving method for inhibiting tumor compound and medicinal compositions containing same
10/31/2001CN1319599A Process for preparing imidazolinone
10/31/2001CN1319594A Diazesuberane derivant or its salt
10/31/2001CN1319593A Process for prpearing 11-amino-3-chlorine-6,11-dihydrogen-5,5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine
10/31/2001CN1319587A Heterocyclonitrogen heteroethane derivant with antiviral activity
10/31/2001CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method
10/31/2001CN1319420A Medicine for treating asthma
10/31/2001CN1319416A Liquid medicine for treating influenza virus and preparation process thereof
10/31/2001CN1319402A 眼部营养素 Eye Nutrients
10/31/2001CN1319399A Medicine for curing burn and scald
10/31/2001CN1319398A Fructose-1,6-magnesium diphosphate injection and productive method thereof
10/31/2001CN1319397A Anticancer medicine and preparation process thereof
10/31/2001CN1319396A Medicinal composition
10/31/2001CN1319395A Refapentine or rifampin liposome perfusate, injection and preparation process thereof
10/31/2001CN1319394A Easy effervescent, moistureproof antiseptic antiphlogistic tablet and preparation process thereof
10/31/2001CN1319393A Application of chrysophanic acid in curing hyperlipemia
10/31/2001CN1319392A Pharmaceutical use of gorgonian acid
10/31/2001CN1319391A Active content contained floating form having polyacetic vinylester and polyvinyl pyrrolidone, its preparation and use
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073991C Antilysin used reverse transcription enzyme inhibitor crystallizing technology
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/31/2001CN1073851C High efficiency ointment for curing beri-beri (tinea pedis)